Like what you read? Get new posts delivered straight to your inbox!
Contact Us | Follow Us
Experience. Integrity. IMPACT.
What We Do

Rebecca Pogue, PhD, Promoted to Consultant

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In February 2020, Rebecca Pogue, PhD, was promoted to the position of Consultant at Impact Pharmaceutical Services, Inc. (IMPACT).

Rebecca joined IMPACT in October 2017 with over 10 years of medical writing experience within CRO and pharmaceutical environments, having worked on numerous types of early and late phase regulatory documents. Since joining IMPACT, Rebecca has continued working on an increasing breadth and complexity of documents, including pivotal CSRs (many with complex statistical plans), briefing documents, marketing application submission components, and responses to regulatory agency questions. In addition, as one of our senior reviewers, Rebecca has been praised for her willingness to take the time to teach and mentor her colleagues, ensuring they understand both the scientific and regulatory aspects of their projects.

Most recently, Rebecca took on the project management of a global program at the marketing application stage of development. Her leadership and efforts on this project have been instrumental, as she has adapted to several strategic changes by the team. Despite the changes, Rebecca continues to guide the team with the implementation of new processes whilst balancing the development of plans for post‑approval activities and several country-specific submissions.

“The promotion of Rebecca to Consultant is incredibly well deserved,” said Chrissy Williams, IMPACT Associate Director of Medical Writing and Submission Management. “Rebecca has an outstanding scientific ability to author a wide array of regulatory documents that often exceed client expectations. Rebecca is also the consummate team player who forms true partnerships with our clients. In addition, her desire to help and educate those around her is a great asset to not only to her more junior colleagues but also her peers. We are very lucky to have Rebecca at IMPACT, and I appreciate everything she brings to the team, IMPACT, and our clients.”

Tim Garver, Executive Vice President and COO at IMPACT, comments, “Rebecca embodies all of the desirable traits of an experienced Consultant: she provides program-wide recommendations with regard to submission strategy and brings a wealth of process and planning expertise to each of her projects. In addition to her expert knowledge of regulatory submissions, she has demonstrated a true love of mentoring, and everyone serving on her project teams (on the IMPACT and Sponsor sides) benefits from her guidance.”

IMPACT is a Contract Research Organization (CRO) located in Research Triangle Park, NC. Our team consists of drug development professionals who specialize in medical writing and quality control, drug development consulting, regulatory affairs, regulatory operations, and program management.

Media Contact:

Mark A. Cierpial, PhD, Chief Executive Officer
Phone: (919) 899-9248
Fax: (919) 354-6090
mcierpial@impactpharma.com
www.impactpharma.com

6

Leave a Reply

Your email address will not be published. Required fields are marked *